Quantcast

Latest Eastern Cooperative Oncology Group Stories

2014-02-03 08:27:30

WALTHAM, Mass., Feb. 3, 2014 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., today announced the appointment of distinguished breast cancer specialist, George W. Sledge, Jr., M.D., to its board of directors as an independent director. Dr. Sledge is currently professor and chief of medical oncology at Stanford University Medical Center. He specializes in the study and treatment of breast cancer and directed the first large, nationwide study on the use of paclitaxel to treat advanced...

2014-01-09 23:01:40

Blinatumomab, the first BiTE® antibody to be developed for the treatment of cancer, is being investigated by the ECOG-ACRIN Cancer Research Group in its latest trial, E1910. Philadelphia, PA (PRWEB) January 09, 2014 The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) announced today that it has activated E1910, a randomized phase III clinical trial comparing overall survival after treatment with blinatumomab in combination with chemotherapy vs. chemotherapy alone in adults aged 35 to...

2013-12-13 23:01:59

An analysis by ECOG-ACRIN researchers shows that TILs are a prognostic factor in women with triple negative breast cancer. San Antonio, TX (PRWEB) December 13, 2013 An analysis presented by researchers from the ECOG-ACRIN Cancer Research Group this week at the San Antonio Breast Cancer Symposium showed that stromal tumor-infiltrating lymphocytes (TILs) represent a robust prognostic factor in patients with triple-negative breast cancer (TNBC) who are treated with standard adjuvant...

2013-12-09 23:21:19

Results from an ECOG-ACRIN Cancer Research Group trial show the benefit of using the combination of docetaxel and ADT as initial treatment. Philadelphia, PA (PRWEB) December 09, 2013 Men suffering from highly advanced prostate cancer have new hope for longer survival times based on a recent clinical trial, the interim results of which were just announced by the National Institutes of Health. The findings suggest that physicians can immediately consider changing their clinical practice...

2013-12-09 23:02:27

18 percent of lung cancers detected by low-dose CT are indolent according to ECOG-ACRIN Cancer Research Group study. Philadelphia, PA (PRWEB) December 09, 2013 An analysis of data from the National Lung Screening Trial (NLST), the results of which were published today in JAMA Internal Medicine, suggests that more than 18 percent of lung cancers detected by low-dose computed tomography (LDCT or low-dose CT) may be indolent. “This is another important piece of information that helps us...

2013-08-20 23:23:18

The affiliation allows further collaboration to advance cancer research. Fort Myers, FL and Scottsdale, AZ (PRWEB) August 20, 2013 21st Century Oncology today announced it will more closely combine cancer research initiatives with Massachusetts General Hospital (MGH), the original and largest teaching affiliate of Harvard Medical School (HMS). Currently, 21st Century Oncology, the largest U.S. radiation therapy provider, conducts cancer research alongside MGH within the framework of the...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related